1. COVID-19 Vaccine Development At Early Stage In India: Experts  NDTV
  2. How one Indian company could be world's door to a Covid-19 vaccine  Livemint
  3. We must be very careful & manage people's expectation regarding the Covid vaccine : Adar Poonawalla  ThePrint
  4. Coronavirus vaccine update: Oxford vaccine enters the advanced trials and ICMR finds HCQ effective, expan  Times of India
  5. Hoping for a Covid-19 vaccine in India by October? Here is what you need to know  India Today
  6. View Full coverage on Google News
As Indian firms scramble to develop a vaccine for coronavirus, experts feel that research in the country is still at a nascent stage and any concrete breakthrough is not likely within a year.As Indian firms scramble to develop a vaccine for coronavirus, experts feel that research in the country is still at a nascent stage and any concrete breakthrough is not likely within a year.

Coronavirus Pandemic: COVID-19 Vaccine Development At Early Stage In India, Breakthrough Unlikely Within A Year: Experts

Serum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus.The Serum Institute produces more than 1.5 billion doses of vaccines every year, for everything from polio to measlesSerum Institute, the world's largest manufacturer of vaccines by volume, is working on several candidates for the novel coronavirus.The Serum Institute produces more than 1.5 billion doses of vaccines every year, for everything from polio to measles

How one Indian company could be world's door to a Covid-19 vaccine

Oxford University scientists, working to develop a vaccine for COVID-19, have started recruiting candidates for Phases II and III of human clinical trials.Oxford University scientists, working to develop a vaccine for COVID-19, have started recruiting candidates for Phases II and III of human clinical trials.

Oxford researchers announce phase II and phase III human trials of COVID-19 vaccine - Republic World

The aim is to find a safe vaccine that will develop immunity against the virus and prevent the disease from spreading The aim is to find a safe vaccine that will develop immunity against the virus and prevent the disease from spreading

500 people in one part of Wales set to take part in groundbreaking coronavirus vaccine trial - Wales Online

403 Missing Auth Token

Bloomberg - Are you a robot?

“The U.S. government is providing billions to the drug companies to develop a COVID-19 vaccine. Once that vaccine is approved by the FDA, it must be available to all for free. We've already paid for it. This is not a time for pharmaceutical industry profiteering.”

Bernie Sanders on Twitter: "The U.S. government is providing billions to the drug companies to develop a COVID-19 vaccine. Once that vaccine is approved by the FDA, it must be available to all for free. We've already paid for it. This is not a time for pharmaceutical industry profiteering."

“Thank you to this science teacher who came to my aid when I was confronted by an angry constituent upset by my support of vaccines as I handed out #ppe this morning! In this era of #covid19, science-based policy is… https://t.co/JupnwqxOeU”

Senator Brad Hoylman on Twitter: "Thank you to this science teacher who came to my aid when I was confronted by an angry constituent upset by my support of vaccines as I handed out #ppe this morning! In this era of #covid19, science-based policy is… https://t.co/JupnwqxOeU"

“Worth reading on covid vaccines: be ready for something more like a flu vaccine, than the smallpox one. (But we mustn't let the perfect be the enemy of the good) https://t.co/zeIYtFifK4 via @statnews”

Evan Davis on Twitter: "Worth reading on covid vaccines: be ready for something more like a flu vaccine, than the smallpox one. (But we mustn't let the perfect be the enemy of the good) https://t.co/zeIYtFifK4 via @statnews"

“This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering.”

Bernie Sanders on Twitter: "This is what our government is paying to develop a COVID19 vaccine: - $1.2 billion to AstraZeneca - $483 million to Moderna - $500 million to Johnson & Johnson - $30 million to Sanofi Once a vaccine is approved by the FDA, it must be available to all for free. No profiteering."

THOUSANDS more volunteers are needed for the latest rounds of clinical trials for a promising coronavirus vaccine. Researchers say their world- ­leading jab is “progressing very well” and it is rea…

Thousands of volunteers needed for latest clinical trials of ‘promising’ coronavirus vaccine – The Sun

THE US has purchased around 300 million COVID-19 vaccines from AsteaZeneca.THE US has purchased around 300 million COVID-19 vaccines from AsteaZeneca.

Coronavirus US: 300 million AstraZeneca vaccines bought | World | News | Express.co.uk

The US government will make as much as $1.2 billion available to accelerate testing and production of a potential Covid-19 vaccine developed by the University of Oxford.Astrazeneca, the drugmakerThe US government will make as much as $1.2 billion available to accelerate testing and production of a potential Covid-19 vaccine developed by the University of Oxford.Astrazeneca, the drugmaker

Some media reports in India suggest that a Covid-19 vaccine may become available in the market as early as October. How realistic are these hopes and how far are we actually from that coveted shot in the arm?Some media reports in India suggest that a Covid-19 vaccine may become available in the market as early as October. How realistic are these hopes and how far are we actually from that coveted shot in the arm?

Hoping for a Covid-19 vaccine in India by October? Here is what you need to know - SCIENCE News

The race towards finding a coronavirus vaccine has ntensifiesd as the virus has infected more than 5 million people till noThe race towards finding a coronavirus vaccine has ntensifiesd as the virus has infected more than 5 million people till no

Coronavirus vaccine update: Oxford vaccine enters the advanced trials and ICMR finds HCQ effective, expands its use - Times of India

Here is a preview of the top Covid-19 news today from India and the world.Here is a preview of the top Covid-19 news today from India and the world.

RBI cuts key rate, Oxford vaccine trials in next phase: Covid-19 news today - india news - Hindustan Times

403 Forbidden

Countries across the world are pinning their hopes on the Oxford University's vaccine with pharma behemoths like AstraZeneca already aboard for the expeditious production of the vaccine.Countries across the world are pinning their hopes on the Oxford University's vaccine with pharma behemoths like AstraZeneca already aboard for the expeditious production of the vaccine.

Coronavirus vaccine: Oxford University, AstraZeneca start advanced trials of COVID-19 drugs

If the world is to gain access to a vaccine for COVID-19, there's a good chance it will pass through the doors of Serum Institute of India. For latest updates and live news on coronavirus, click hereIf the world is to gain access to a vaccine for COVID-19, there's a good chance it will pass through the doors of Serum Institute of India. For latest updates and live news on coronavirus, click here

Coronavirus: How one Indian company could be world's door to a COVID-19 vaccine | Deccan Herald

AstraZeneca is also in discussions with the Serum Institute of India and other potential partners to increase production and distribution.AstraZeneca is also in discussions with the Serum Institute of India and other potential partners to increase production and distribution.

AstraZeneca receives $1bn US investment for Oxford vaccine, Health News, ET HealthWorld

Astra plans to make as many as 30 million doses available in Britain as early as September.Astra plans to make as many as 30 million doses available in Britain as early as September.

Oxford, AstraZeneca begin advanced trials of Covid vaccine | coronavirus outbreak News,The Indian Express

Serum Institute chief says the potential vaccine is based on a tried-and-tested platformSerum Institute chief says the potential vaccine is based on a tried-and-tested platform

Coronavirus | 80% success chance for Oxford vaccine trials, says Serum Institute chief - The Hindu

The London Economic |"That is going to mean a lot of elderly are going to die and those with heart conditions and diabetes and other risk factors.' | NewsThe London Economic |"That is going to mean a lot of elderly are going to die and those with heart conditions and diabetes and other risk factors.' | News

Herd immunity without vaccine or treatment is a 'Darwinian policy'

British researchers testing an experimental vaccine against the new coronavirus are moving into advanced studies and aim to immunize more than 10,000 people to determine if the shot works.

UK to start huge vaccine test; China reports promising hints (Update)

On Friday, the University of Oxford said that the researchers have begun recruiting adults and children for advanced human trials of the vaccine.On Friday, the University of Oxford said that the researchers have begun recruiting adults and children for advanced human trials of the vaccine.

Early progress has been reported on several vaccine efforts, as scientists around the world scramble to test ways to protect people from the coronavirus.Early progress has been reported on several vaccine efforts, as scientists around the world scramble to test ways to protect people from the coronavirus.

The United States has secured almost a third of the first one billion doses planned for AstraZeneca's experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble for medicines to get their economies back to work.The United States has secured almost a third of the first one billion doses planned for AstraZeneca's experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble for medicines to get their economies back to work.

‘America first’: US secures 300 million doses of potential UK COVID-19 vaccine – EURACTIV.com

British pharmaceutical company AstraZeneca says it is ready to provide a potential vaccine against the new coronavirus from September.British pharmaceutical company AstraZeneca says it is ready to provide a potential vaccine against the new coronavirus from September.

British firm ready to supply vaccine in September | NHK WORLD-JAPAN News

AstraZeneca has announced a deal to distribute 400 million doses of Oxford Uni's coronavirus vaccine, but the vaccine may not work.AstraZeneca has announced a deal to distribute 400 million doses of Oxford Uni's coronavirus vaccine, but the vaccine may not work.

3 Reasons Why Oxford’s Record-Breaking COVID-19 Vaccine is a Risky Bet

The second phase of COVID-19 vaccine trials by the University of Oxford aims to assess the immune response to the vaccine in people of different age groupsThe second phase of COVID-19 vaccine trials by the University of Oxford aims to assess the immune response to the vaccine in people of different age groups

Children, adults over 70 to now be included in COVID-19 vaccine clinical trials | coronavirus outbreak News,The Indian Express

RTL Today - Second-highest death toll: Virus-stung UK banks on vaccine drive

The University of Oxford said on Friday that its researchers have begun recruiting adults and children for advanced human trials of a COVID-19 vaccine that will involve up to 10,260 volunteers across the UKThe University of Oxford said on Friday that its researchers have begun recruiting adults and children for advanced human trials of a COVID-19 vaccine that will involve up to 10,260 volunteers across the UK

Oxford COVID-19 vaccine enters advanced human trials

LONDON, May 22 — The United States has secured almost a third of the first 1 billion doses planned for AstraZeneca's experimental Covid-19 vaccine by pledging up to US$1.2 billion (RM5.22 billion), as world powers scramble for medicines to get their economies back to work. While not yet proven to...LONDON, May 22 — The United States has secured almost a third of the first 1 billion doses planned for AstraZeneca's experimental Covid-19 vaccine by pledging up to US$1.2 billion (RM5.22 billion), as world powers scramble for medicines to get their economies back to work. While not yet proven to...

US secures 300 million doses of potential AstraZeneca Covid-19 vaccine | World | Malay Mail

Biotech companies and drugmakers are speeding up development of a vaccine for COVID-19. This has seen many big players joining forces to come up with a treatment.Biotech companies and drugmakers are speeding up development of a vaccine for COVID-19. This has seen many big players joining forces to come up with a treatment.

Coronavirus Vaccine Race Pushes Up Pharma Giants' Production

LONDON: A team of researchers has begun recruiting volunteers for clinical trials of a vaccine against COVID-19, while another team has started work on a treatment that may help critically ill patients recover from the disease.LONDON: A team of researchers has begun recruiting volunteers for clinical trials of a vaccine against COVID-19, while another team has started work on a treatment that may help critically ill

Researchers begin trials of COVID-19 vaccine | Arab News

Health: INSIGHT: How one Indian company could be world's door to a Covid-19 vaccine

The firm AstraZeneca has concluded deals for 400 million doses of the vaccine currently being developed within Oxford University. The company said that it is capable of producing over one billion doses of the AZD1222 vaccine for this year and the next.The firm AstraZeneca has concluded deals for 400 million doses of the vaccine currently being developed within Oxford University. The company said that it is capable of producing over one billion doses of the AZD1222 vaccine for this year and the next.

COVID-19 Vaccine: AstraZeneca to Supply 400 Million Potential Vaccines by September After Partnering with Oxford University | Tech Times

A VACCINE may not be possible for the coronavirus, according to Scotland’s national clinical director.A VACCINE may not be possible for the coronavirus, according to Scotland’s national clinical director.

Jason Leitch warns vaccine may never be found for coronavirus | The National

US secures 300 million. Read more at straitstimes.com.World News -US secures 300 million. Read more at straitstimes.com.

In Brief: US secures 300 million possible vaccine doses, World News & Top Stories - The Straits Times

HALIFAX — An early trial of a prospective COVID-19 vaccine that will soon be tested on Canadians has found it to be safe and effective at prompting an immune response. A study published Friday in the Lancet says the formulation from China's CanSino Biologics Inc. needs more trials to determine whether it can actually protect against SARS-CoV-2, the virus that causes COVID-19. But it says early trials involving 108 adults in Wuhan produced...

Early results promising for potential COVID-19 vaccine to be tested on Canadians

The head of the Oxford Vaccine Group said Friday that clinic trials on its vaccine for the coronavirus are "progressing very well." 1,000 people have alreadyResearchers at Oxford University said Friday that they would move on to the next phase of testing, expanding its test from 1,000 to some 10,000 more.

The Oxford COVID-19 vaccine is 'progressing very well,' according to the lead scientists, who said 10,000 more people will be inoculated | Business Insider India

A new poll from Reuters and Ipsos has found that a quarter of Americans weren't interested in taking a Covid-19 vaccine, which doesn't even exist.Covid-19 has wreaked havoc on the world, causing 5 million recorded infections and 333,000 deaths so far, with a third of the world under lockdown. In orde

A Quarter Of Americans Are Hesitant About Taking A Covid-19 Vaccine That Doesn't Yet Exist | IFLScience

This stock is making big moves on the heels of positive interim data from phase 1 human trials of Moderna's COVID-19 vaccine candidate.This stock is making big moves on the heels of positive interim data from phase 1 human trials of Moderna's COVID-19 vaccine candidate.

Moderna Shares Up Almost 250% This Year as Vaccine Trials Continue | The Motley Fool

British researchers testing an experimental vaccine against the new coronavirus aim to immunize more than 10,000 people to find out if it works.British researchers testing an experimental vaccine against the new coronavirus aim to immunize more than 10,000 people to find out if it works.

Over 10,000 to receive potential COVID-19 vaccine in U.K. as tests expand - National | Globalnews.ca

An early trial of a prospective COVID-19 vaccine that will soon be tested on Canadians has found it to be safe and effective at prompting an immune response.An early trial of a prospective COVID-19 vaccine that will soon be tested on Canadians has found it to be safe and effective at prompting an immune response.

Promising results for potential COVID-19 vaccine to be tested on Canadians | CTV News

ChAdOx1 nCoV-19 is made from a virus (ChAdOx1), which is a weakened version of a common cold virus (adenovirus) that causes infections in chimpanzees, and genetically changed so that it is impossible for it to replicate in humans.ChAdOx1 nCoV-19 is made from a virus (ChAdOx1), which is a weakened version of a common cold virus (adenovirus) that causes infections in chimpanzees, and genetically changed so that it is impossible for it to replicate in humans.

Oxford University’s Covid-19 Vaccine Moves to Next Stage of Human Trial

The Oxford trial will monitor the effects on thousands of people's immune systems.The Oxford trial will monitor the effects on thousands of people's immune systems.

Coronavirus: Children and older adults to take part in vaccine trial - BBC News

A team from Oxford University told NBC News that the expanded trial will allow doctors to determine how effective the shot is at preventing COVID-19.A promising experimental vaccine for the coronavirus hit a milestone Friday, with British researchers announcing they will be progressing to advanced stages of human trials. The team from

Coronavirus vaccine shows promise, progresses to advanced trial

LONDON (AP) -- Drug maker AstraZeneca secured its first agreements Thursday for 400 million doses of a COVID-19 vaccine, bolstered by an investment frLONDON (AP) -- Drug maker AstraZeneca secured its first agreements Thursday for 400 million doses of a COVID-19 vaccine, bolstered by an investment fr

AstraZeneca secures orders for COVID-19 vaccine - The Mainichi

AstraZeneca, a drugmaker to produced Oxford University's potential COVID-19 vaccine, says it looks to begin supply in September if clinical trials succeed.AstraZeneca, a drugmaker to produced Oxford University's potential COVID-19 vaccine, says it looks to begin supply in September if clinical trials succeed.

Potential COVID-19 vaccine could be ready in September, says AstraZeneca - TheCable Lifestyle

COVID-19 vaccine trials are to take place across central Scotland.COVID-19 vaccine trials are to take place across central Scotland.

Glasgow joins crucial trials to test vaccine | Glasgow Times

wish list